Navigation Links
US Patent Office rejects company's claim for bean commonly grown by Latin American farmers
Date:4/30/2008

WASHINGTON, DC (30 APRIL 2008)The United States Patent and Trademark Office (USPTO) today rejected all of the patent claims for a common yellow bean that has been a familiar staple in Latin American diets for more than a century.

The bean was erroneously granted patent protection in 1999, as US Patent Number 5,894,079, in a move that raised profound concerns about biopiracy and the potential abuse of intellectual property (IP) claims on plant materials that originate in the developing world and remain as important dietary staples, particularly among the poor.

A research center, the International Center for Tropical Agriculture (known by its Spanish acronym, CIAT), which is supported by the Consultative Group on International Agricultural Research (CGIAR), led the legal challenge to the patent through the USPTOs reexamination process.

We are happy that the patent office has reached a final decision in this case but remain concerned that the ex partes patent reexamination procedure meant that these patent claims remained in force for such a long time, said Geoffrey Hawtin, Director General of CIAT, which has been fighting the patent since 2001. For several years now, farmers in Mexico, the USA and elsewhere have unnecessarily endured legal threats and intimidation for simply planting, selling or exporting a bean that they have been growing for generations.

At issue is a hearty and nutritious yellow beansimilar to the pinto beanthat is known to plant breeders as Phaseolus vulgaris but is commonly called azufrado or Mayocoba bean by Latin American farmers and consumers. In the 1990s, a Colorado man, Larry Proctor, bought some beans in a market in Mexico and after a few years of plantings, claimed he had developed what he called a new field bean variety that produces distinctly colored yellow seed which remains relatively unchanged by season. He dubbed it the Enola bean, filed a patent application and obtained a 20-year patent t
'/>"/>

Contact: Ellen Wilson
ewilson@burnesscommunications.com
301-652-1558 ext. 5723
Burness Communications
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. bioMETRX, Inc. Acquires Patent for Biometric Padlock
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
4. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
5. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
6. Cornell patents a pink lily look-alike that blooms all summer long
7. Biotechnology needs 21st century patent system: Expert
8. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
9. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
10. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
11. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
... gradual extinction of cold-loving species, and the European land ... from the University of Kassel in Germany and the ... that human-induced temperature increases over a 40-year period in ... the near extinction of the local land leech Xerobdella ...
... have long known that the human body runs like clockwork, ... of light and darkness. Now a team of researchers is ... activity, which could allow them to predict optimal timing for ... solar day and relieve psychosocial stress. In short, ...
... showing that dog-walking in bushland significantly reduces bird ... against the practice in sensitive bushland and conservation ... the ecological impacts of dog-walking have remained subjective ... But the first clear evidence that birds ...
Cached Biology News:Role reversal as humans suck life out of leeches 2Researchers developing device to predict proper light exposure for human health 2Researchers developing device to predict proper light exposure for human health 3A dog in the hand scares birds in the bush 2
(Date:7/24/2014)... Research and Markets has announced the addition ... Market 2014-2018" report to their offering. ... the study of the gene and its functions and ... of proteomes or sets of proteins by using molecular ... mapping of genes and DNA sequencing to understand the ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2
... 28 , - Guests Will ... , Staying healthy in these stressful ... Attitude Health Retreats early in 2009 may provide,participants with the ... A key component of the retreat ...
... XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , ... it received a Staff Determination Letter (the "Letter") from ... the staff of Nasdaq,s Listing Qualifications Department determined, using ... the Company,s American Depository Shares ("ADRs") would be delisted ...
... web based CTMS (Clinical Trial Management System), has ... deployed visit reports, site payments, sponsor portal and ... project will include integration to our electronic data ... as other innovative functional changes to the system ...
Cached Biology Technology:New Health Retreat Gives a Fresh Attitude Towards Disease Prevention 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 3
...
...
... White solid. PROTECT FROM LIGHT. ... sulfanamido-benzbromarone compound that acts as a ... of PTP1B (IC 50 = ... PTP1B 403 and PTP1B 298 ...
...
Biology Products: